Moreover, one of the major lipid constituents in royal jelly is 10-hydroxy-2-decenoic acid, which was said to exert anti-inflammatory consequences in colon cancer cells passing through inhibiting NF-κB, which further inhibited the release of TNF-α. The gene discussed is TNF; the disease is malignant colon neoplasm.